{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:43:19Z","timestamp":1790624599673,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41372-021-01252-x","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T19:42:44Z","timestamp":1635450164000},"page":"14-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Use of inhaled nitric oxide in preterm vs term\/near-term neonates with pulmonary hypertension: results of the PaTTerN registry study"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3722-3035","authenticated-orcid":false,"given":"Leif","family":"Nelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry E.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8612-2073","authenticated-orcid":false,"given":"Eugenia K.","family":"Pallotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim L.","family":"Potenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","volume":"83","author":"C Frostell","year":"1991","unstructured":"Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83:2038\u201347.","journal-title":"Circulation"},{"key":"1252_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","volume":"78","author":"CG Frostell","year":"1993","unstructured":"Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427\u201335.","journal-title":"Anesthesiology"},{"key":"1252_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJM200002173420704","volume":"342","author":"RH Clark","year":"2000","unstructured":"Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med. 2000;342:469\u201374.","journal-title":"N Engl J Med"},{"key":"1252_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1542\/peds.101.3.325","volume":"101","author":"D Davidson","year":"1998","unstructured":"Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO\/PPHN Study Group. Pediatrics. 1998;101:325\u201334.","journal-title":"Pediatrics"},{"key":"1252_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM199702273360901","volume":"336","author":"The Neonatal Inhaled Nitric Oxide Study Group.","year":"1997","unstructured":"The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group [published correction appears in N Engl J Med. 1997;337:434]. N Engl J Med. 1997;336:597\u2013604.","journal-title":"N Engl J Med"},{"key":"1252_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1542\/peds.2010-3507","volume":"127","author":"FS Cole","year":"2011","unstructured":"Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D, et al. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127:363\u20139.","journal-title":"Pediatrics"},{"key":"1252_CR7","unstructured":"Schreiber MD. Response to Kumar on behalf of the AAP committee on fetus and newborn. Pediatrics. 2014. https:\/\/pediatrics.aappublications.org\/content\/133\/1\/164\/tab-e-letters#response-to-kumar-on-behalf-of-the-aap-committee-on-fetus-and-newborn."},{"key":"1252_CR8","doi-asserted-by":"crossref","unstructured":"The Franco-Belgium Colalborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group. Lancet. 1999;354:1066\u201371.","DOI":"10.1016\/S0140-6736(99)03309-7"},{"key":"1252_CR9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1542\/peds.2004-1209","volume":"115","author":"D Field","year":"2005","unstructured":"Field D, Elbourne D, Truesdale A, Grieve R, Hardy P, Fenton AC, et al. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339). Pediatrics. 2005;115:926\u201336.","journal-title":"Pediatrics"},{"key":"1252_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0140-6736(99)03558-8","volume":"354","author":"JP Kinsella","year":"1999","unstructured":"Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999;354:1061\u20135.","journal-title":"Lancet"},{"key":"1252_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.jp.7211881","volume":"28","author":"PH Su","year":"2008","unstructured":"Su PH, Chen JY. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure. J Perinatol. 2008;28:112\u20136.","journal-title":"J Perinatol"},{"key":"1252_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa043927","volume":"353","author":"KP Van Meurs","year":"2005","unstructured":"Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13\u201322.","journal-title":"N Engl J Med"},{"key":"1252_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa060442","volume":"355","author":"JP Kinsella","year":"2006","unstructured":"Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355:354\u201364.","journal-title":"N Engl J Med"},{"key":"1252_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.jp.7211690","volume":"27","author":"KP Van Meurs","year":"2007","unstructured":"Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, et al. Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure. J Perinatol. 2007;27:347\u201352.","journal-title":"J Perinatol"},{"key":"1252_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0140-6736(10)60664-2","volume":"376","author":"JC Mercier","year":"2010","unstructured":"Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, et al. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet. 2010;376:346\u201354.","journal-title":"Lancet"},{"key":"1252_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapediatrics.2017.2618","volume":"171","author":"SU Hasan","year":"2017","unstructured":"Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, et al. Effect of inhaled nitric oxide on survival without bronchopulmonary dysplasia in preterm infants: a randomized clinical trial. JAMA Pediatr. 2017;171:1081\u20139.","journal-title":"JAMA Pediatr"},{"key":"1252_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/jp.2016.112","volume":"36","author":"Q Jiang","year":"2016","unstructured":"Jiang Q, Gao X, Liu C, Chen D, Lin X, Xia S, et al. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia. J Perinatol. 2016;36:883\u20139.","journal-title":"J Perinatol"},{"key":"1252_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jpeds.2014.06.018","volume":"165","author":"JP Kinsella","year":"2014","unstructured":"Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, et al. Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. J Pediatr. 2014;165:1104\u20131108.e1101.","journal-title":"J Pediatr"},{"key":"1252_CR19","doi-asserted-by":"publisher","first-page":"F185","DOI":"10.1136\/fn.77.3.F185","volume":"77","author":"NV Subhedar","year":"1997","unstructured":"Subhedar NV, Ryan SW, Shaw NJ. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;77:F185\u2013190.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1252_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/08035250600702594","volume":"95","author":"C Dani","year":"2006","unstructured":"Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF. Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr. 2006;95:1116\u201323.","journal-title":"Acta Paediatr"},{"key":"1252_CR21","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMoa031154","volume":"349","author":"MD Schreiber","year":"2003","unstructured":"Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349:2099\u2013107.","journal-title":"N Engl J Med"},{"key":"1252_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa061088","volume":"355","author":"RA Ballard","year":"2006","unstructured":"Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation: the NO CLD Study Group. N Engl J Med. 2006;355:343\u201353.","journal-title":"N Engl J Med"},{"key":"1252_CR23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","volume":"132","author":"SH Abman","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037\u201399.","journal-title":"Circulation"},{"key":"1252_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1542\/peds.2013-3444","volume":"133","author":"P Kumar","year":"2014","unstructured":"Kumar P. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133:164\u201370.","journal-title":"Pediatrics"},{"key":"1252_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1515\/jpm-2017-0040","volume":"46","author":"S Suzuki","year":"2018","unstructured":"Suzuki S, Togari H, Potenziano JL, Schreiber MD. Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience. J Perinat Med. 2018;46:657\u201363.","journal-title":"J Perinat Med"},{"key":"1252_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.clinthera.2019.03.008","volume":"41","author":"WD Rhine","year":"2019","unstructured":"Rhine WD, Suzuki S, Potenziano JL, Escalante S, Togari H. An analysis of time to improvement in oxygenation in Japanese preterm and late preterm or term neonates with hypoxic respiratory failure and pulmonary hypertension. Clin Ther. 2019;41:910\u20139.","journal-title":"Clin Ther"},{"key":"1252_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/sim.4780091208","volume":"9","author":"CP Farrington","year":"1990","unstructured":"Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990;9:1447\u201354.","journal-title":"Stat Med"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01252-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:08:08Z","timestamp":1643018888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-01252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1038\/s41372-021-01252-x","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"24 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JPK received an investigator-initiated grant from Mallinckrodt to fund a registry for preterm newborns with pulmonary hypertension. ET is an employee of Mallinckrodt Pharmaceuticals and may hold stock or stock options in that company. JLP is a former employee of Mallinckrodt Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}